This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Free Online Activities

Cost-Effectiveness Measures, Methods, and Policy Implications From the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia

Robert A. Rosenheck, MD, and Chair, Jeffrey A. Lieberman, MD

Published: February 15, 2007

Article Abstract

Salesof atypical antipsychotics have expanded rapidly as their use for treatment ofschizophrenia and other illnesses has increased. The CATIE trial was designedto evaluate the cost-effectiveness of these medications. Cost-effectivenessanal’ ‹ysis in CATIE examined the benefits and costs of treatments and attemptedto determine whether one treatment would result in better outcomes and lowercosts than another one. While the data from CATIE on cost-effectiveness havenot been analyzed yet, it is still possible to consider the potential implicationsof the analysis, including how the roles of researchers and stakeholders shouldbe considered in deciding optimal clinical practices and public policies.

See the entire activity.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 68

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Prevalence and Correlates of Obsessive-Compulsive Symptoms in Individuals With Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder

Prevalence and correlates of obsessive-compulsive symptoms and OCD were identified from the case records of over 22,500...